Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant
Condition(s):Hepatocellular Carcinoma Recurrent; Hepatocellular CarcinomaLast Updated:January 31, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Hepatocellular Carcinoma Recurrent; Hepatocellular CarcinomaLast Updated:January 31, 2024Completed
Condition(s):Portal Hypertension; Cirrhosis; Esophageal Varices; Gastric Varices Bleeding; Varice Bleed; Liver Diseases; Liver CirrhosisLast Updated:March 14, 2023Completed
Condition(s):Bleeding Esophageal Varices; CirrhosisLast Updated:December 24, 2020Completed
Condition(s):Atrial Fibrillation; Heart FailureLast Updated:April 4, 2013Terminated
Condition(s):HypertensionLast Updated:May 26, 2008Completed
Condition(s):Coronary Microvascular DiseaseLast Updated:May 19, 2021Completed
Condition(s):Beta Blocker Intolerance; Congestive Heart FailureLast Updated:February 24, 2017Completed
Condition(s):Cardiac Amyloidosis; Heart DiseasesLast Updated:December 5, 2023Recruiting
Condition(s):Heart Failure With Reduced Ejection FractionLast Updated:December 5, 2022Recruiting
Condition(s):Liver Cirrhosis; Portal Hypertension.Last Updated:January 25, 2011Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.